New Obesity clinical trials: 1,940 posted since Nov 2024

Name: New Obesity clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Obesity clinical trials: 1,940 rows for $97, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 107 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/obesity, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

1,940 clinical studies in obesity were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 527 have an industry sponsor and 1,128 are recruiting or about to. The newest, NCT07926152, was posted on November 9, 2026: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (German Diabetes Center).

The request: Every new Obesity clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

1,940New trials
527Industry sponsored
1,128Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 1,940, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926152	Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes	German Diabetes Center	Not applicable	Not yet recruiting	Type 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia	94	Germany	clinicaltrials.gov
November 9, 2026	NCT07925684	Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients	Jianbo Wu	Not applicable	Recruiting	Procedural Sedation and Analgesia, Obesity & Overweight	120	China	clinicaltrials.gov
November 9, 2026	NCT07925294	The Impact of Myofunctional Therapy on Children With Sleep Apnea and Obesity	Université Catholique de Louvain	Not applicable	Not yet recruiting	Obstructive Sleep Apnea (OSA) and Obesity	62		clinicaltrials.gov
November 9, 2026	NCT07924761	A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living...	Kailera	Phase 1	Not yet recruiting	Overweight or Obesity	60	United States	clinicaltrials.gov
November 9, 2026	NCT07924618	Ocular Changes in Patients Using Tirzepatide or Semaglutide	Istanbul University	Observational	Recruiting	Type 2 Diabetes Mellitus, Obesity	40	Turkey (Türkiye)	clinicaltrials.gov
November 9, 2026	NCT07924436	Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes	Pamukkale University	Not applicable	Recruiting	Obesity, Diabetes Mellitus, Type 2	30	Turkey (Türkiye)	clinicaltrials.gov
November 9, 2026	NCT07924267	A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic...	EktaH	Phase 1	Completed	Obesity & Overweight, Overweight (BMI > 30)	120	Tunisia	clinicaltrials.gov
November 6, 2026	NCT07923513	Compulsive Eating and Brain's Reward System in Different Pathologies	University Hospital, Clermont-Ferrand	Not applicable	Not yet recruiting	PARKINSON DISEASE (Disorder), Bipolar 1 Disorder, Obesity (BMI>30)	150	France	clinicaltrials.gov
November 6, 2026	NCT07923240	Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional...	Research Center of Neurology, Russia	Phase 4	Active not recruiting	Metabolic Abnormalities, Obesity & Overweight, Cerebral Atherosclerosis, Cerebrovascular Disease	30	Russia	clinicaltrials.gov
November 6, 2026	NCT07922798	A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy...	The United Bio-Technology (Hengqin) Co., Ltd.	Phase 1	Not yet recruiting	Overweight , Obesity	60	China	clinicaltrials.gov
November 6, 2026	NCT07922694	Obesity-Related Indices and Albuminuria in Type 2 Diabetes	Assiut University	Observational	Not yet recruiting	Obesity and Diabetes Mellitus, Type 2, Albuminuria	349		clinicaltrials.gov
November 6, 2026	NCT07922330	A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These...	AstraZeneca	Phase 3	Not yet recruiting	Obesity, Overweight, Type 2 Diabetes Mellitus	330	China, India	clinicaltrials.gov
November 6, 2026	NCT07922005	Lifestyle Interventions and Genetic Scores for Weight Management	National and Kapodistrian University of Athens	Not applicable	Completed	Overweight , Obesity	198	Greece	clinicaltrials.gov
November 6, 2026	NCT07921940	Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy	Medical University of Vienna	Not applicable	Active not recruiting	Obesity & Overweight, Gestational Diabetes Mellitus (GDM), Insulin Resistance, Maternal Obesity Complicating Pregnancy	40	Austria	clinicaltrials.gov
November 6, 2026	NCT07921316	Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous...	Amgen	Phase 1	Not yet recruiting	Obesity, Overweight	356		clinicaltrials.gov
November 5, 2026	NCT07919678	A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)	Pfizer	Phase 3	Recruiting	Obesity, Overweight, Osteoarthritis of the Knee	656	Canada, United States	clinicaltrials.gov
November 5, 2026	NCT07919405	A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Hypertension, Obesity	1,408	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany...	clinicaltrials.gov
November 5, 2026	NCT07919158	Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for...	Rovere Querini Patrizia	Observational	Active not recruiting	Dyslipidemia, Obesity & Overweight	900	Italy	clinicaltrials.gov
November 5, 2026	NCT07918846	A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular Disease	Hoffmann-La Roche	Phase 3	Not yet recruiting	Overweight, Obesity, Cardiovascular Disease	8,200		clinicaltrials.gov
November 4, 2026	NCT07916753	Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition	Fondation Net-Care.ch	Not applicable	Not yet recruiting	Hypertension, Diabetes Mellitus, Type 2, Obesity	1,600	Switzerland	clinicaltrials.gov
November 4, 2026	NCT07916194	A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants	Beijing QL Biopharmaceutical Co.,Ltd	Phase 1	Not yet recruiting	Overweight, Obesity	24	China	clinicaltrials.gov
November 4, 2026	NCT07915986	Brain Dopamine Dynamics in Obesity	Yale University	Phase 1	Not yet recruiting	Obesity	100	United States	clinicaltrials.gov
November 4, 2026	NCT07915609	A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2...	Pfizer	Phase 3	Recruiting	Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2	756	United States	clinicaltrials.gov
November 4, 2026	NCT07915245	A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy	Eli Lilly and Company	Phase 1	Not yet recruiting	Obesity, Overweight	108	Singapore, United States	clinicaltrials.gov
November 3, 2026	NCT07913685	The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight...	Medical University of Bialystok	Phase 4	Completed	Obesity & Overweight	83	Poland	clinicaltrials.gov
November 2, 2026	NCT07911514	A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234	AstraZeneca	Phase 1	Not yet recruiting	Healthy Participants	60	United Kingdom	clinicaltrials.gov
November 2, 2026	NCT07911046	Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity	Erin Mauney	Observational	Not yet recruiting	Pediatric Obesity, Obesity	12	United States	clinicaltrials.gov
November 2, 2026	NCT07910747	Effects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in...	University of Sao Paulo	Not applicable	Not yet recruiting	Obesity (Disorder), Inflammation	60	Brazil	clinicaltrials.gov
November 2, 2026	NCT07909889	Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer	Aarhus University Hospital	Phase 2	Not yet recruiting	Breast Cancer (Early Breast Cancer), Obesity	32	Denmark	clinicaltrials.gov
November 2, 2026	NCT07909772	Effects of a Multispecies Probiotic on Metabolic, Liver, and Gut Health	University of Bari	Not applicable	Completed	Metabolic-Associated Steatotic Liver Disease, Diabetes (DM), Obesity & Overweight	56	Italy	clinicaltrials.gov
November 2, 2026	NCT07908940	Changes in Body Composition Following Pharmacological Treatment for Obesity.	Hospital San Carlos, Madrid	Observational	Enrolling by invitation	Obesity (BMI Equal to or >30), Weight Regain After Bariatric Surgery	116	Spain	clinicaltrials.gov
November 2, 2026	NCT07908823	ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation	Affiliated Hospital to Academy of Military Medical Sciences	Not applicable	Not yet recruiting	Obesity & Overweight	60	China	clinicaltrials.gov
November 2, 2026	NCT07908316	Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After...	Amgen	Phase 1	Recruiting	Obesity, Overweight	180	United States	clinicaltrials.gov
October 30, 2026	NCT07907029	Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight...	Guangdong Provincial Hospital of Traditional Chinese Medicine	Not applicable	Not yet recruiting	Overweight, Obesity	50	China	clinicaltrials.gov
October 29, 2026	NCT07905274	Sarcopenia Risk in Obese T2DM Patients	Bandırma Onyedi Eylül University	Observational	Not yet recruiting	Sarcopenia, Obesity Type 2 Diabetes Mellitus	150	Turkey (Türkiye)	clinicaltrials.gov
October 29, 2026	NCT07904663	The Sleep and Weight Study	NYU Langone Health	Not applicable	Not yet recruiting	Obesity	40	United States	clinicaltrials.gov
October 29, 2026	NCT07903025	Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity	Axomove	Not applicable	Not yet recruiting	Obese Adults	184	France	clinicaltrials.gov
October 29, 2026	NCT07902895	Intrathoracic Sleeve Migration (Sliding Hiatal Hernia) One Year or More After Laparoscopic Sleeve Gastrectomy	Kasr El Aini Hospital	Observational	Completed	Hiatal Hernia, Gastroesophageal Reflux Disease, Obesity, Postoperative Complications	61	Egypt	clinicaltrials.gov
October 29, 2026	NCT07902752	Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs	George Washington University	Phase 2	Not yet recruiting	Obesity & Overweight, Respiratory Depression, Intranasal Drug Administration, Oxytocin, Bariatric Surgery	100		clinicaltrials.gov
October 28, 2026	NCT07902232	Gestational Weight Loss and Restrictive Weight Gain in Maternal Obesity: A Target Trial Emulation	Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School	Observational	Completed	Pregnancy, Obesity, Gestational Hypertension, Gestational Weight Gain	205,636	China	clinicaltrials.gov
October 28, 2026	NCT07901777	Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity	Yuzuncu Yil University	Observational	Recruiting	Obesity & Overweight	200	Turkey (Türkiye)	clinicaltrials.gov
October 28, 2026	NCT07900633	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3,000	Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary...	clinicaltrials.gov
October 28, 2026	NCT07900178	Sustaining Health After an Intensive Weight-loss Pro-gramme	Copenhagen University Hospital, Hvidovre	Observational	Enrolling by invitation	Obesity & Overweight, Weight Loss, Weight Management in Adult Patients With Obesity or Overweight	150	Denmark	clinicaltrials.gov
October 28, 2026	NCT07900074	Mechanisms of Weight Loss: Tirzepatide vs Semaglutide	McMaster University	Phase 4	Recruiting	Obesity (Disorder)	80	Canada	clinicaltrials.gov
October 27, 2026	NCT07898267	Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity	Second Affiliated Hospital of Nanchang University	Not applicable	Not yet recruiting	Obesity & Overweight	150	China	clinicaltrials.gov
October 27, 2026	NCT07897890	Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care	Indiana University	Not applicable	Completed	Obesity & Overweight, Breast Cancer	12	United States	clinicaltrials.gov
October 27, 2026	NCT07897682	Impact of Significant Surgical Reduction of Adipose Tissue on Plasma Levels and Genetic Expression of Adipokines Associated With Ischemic...	King Edward Medical University	Not applicable	Not yet recruiting	Obesity & Overweight, Obesity Type I and II	212	Pakistan	clinicaltrials.gov
October 27, 2026	NCT07897383	Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity	University Hospital, Gentofte, Copenhagen	Phase 1/2	Not yet recruiting	Obesity & Overweight	18		clinicaltrials.gov
October 27, 2026	NCT07897305	Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients	Beijing Anzhen Hospital	Not applicable	Not yet recruiting	Atrial Fibrillation (AF), Ablation Treatment, Obesity & Overweight, Mazdutide	700	China	clinicaltrials.gov
October 26, 2026	NCT07895563	A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control	MNnutra	Not applicable	Active not recruiting	Overweight, Obesity, Weight Management, Appetite Control	170	United States	clinicaltrials.gov
October 26, 2026	NCT07894692	Association of WWI With Difficult Intubation	Cairo University	Observational	Completed	General Anesthesia; Tracheal Intubation	50	Egypt	clinicaltrials.gov
October 26, 2026	NCT07893743	Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.	University Hospital, Gentofte, Copenhagen	Not applicable	Recruiting	Obesity & Overweight	20	Denmark	clinicaltrials.gov
October 26, 2026	NCT07893717	Motivational Interviewing Intervention for Families With Overweight and Obesity	Universidad Autonoma de Baja California	Not applicable	Active not recruiting	Obesity & Overweight	120	Mexico	clinicaltrials.gov
October 26, 2026	NCT07893457	Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity	Mayo Clinic	Phase 4	Not yet recruiting	Obese Adults	30	United States	clinicaltrials.gov
October 23, 2026	NCT07893249	Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention	Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences	Not applicable	Not yet recruiting	Physical Inactivity, Overweight, Obesity	150	China	clinicaltrials.gov
October 23, 2026	NCT07893106	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants...	Ascletis Pharma (China) Co., Limited	Phase 1	Recruiting	Chronic Weight Management	86	United States	clinicaltrials.gov
October 23, 2026	NCT07893093	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants...	Ascletis Pharma (China) Co., Limited	Phase 1	Recruiting	Chronic Weight Management	144	United States	clinicaltrials.gov
October 23, 2026	NCT07891975	Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic Nephropathy	University of Lahore	Not applicable	Completed	Liver Biomarkers, Glucose, Lipid Profiles	102	Pakistan	clinicaltrials.gov
October 23, 2026	NCT07891156	Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2/3	Recruiting	Type 1 Diabetes, Overweight , Obesity	40	Canada	clinicaltrials.gov
October 22, 2026	NCT07890870	A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.	iBio, Inc.	Phase 1	Not yet recruiting	Obesity & Overweight	32	Australia	clinicaltrials.gov
October 22, 2026	NCT07890376	A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes	Eli Lilly and Company	Phase 2	Not yet recruiting	Obesity, Overweight	460	Argentina, United States	clinicaltrials.gov
October 22, 2026	NCT07889570	A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression	Evolv	Not applicable	Completed	Overweight, Obesity, Blood Sugar Regulation, Appetite Suppression, Weight Management	98	United States	clinicaltrials.gov
October 22, 2026	NCT07889453	Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide	LMC Diabetes & Endocrinology Ltd.	Observational	Active not recruiting	Obesity, Type 2 Diabetes (T2D)	650	Canada	clinicaltrials.gov
October 21, 2026	NCT07886788	Study of Grape Consumption in Adaptation to Seasonal Photoperiod	University Rovira i Virgili	Not applicable	Active not recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Overweight, Obesity & Overweight	46	Spain	clinicaltrials.gov
October 21, 2026	NCT07884994	HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform	Universitätsklinikum Hamburg-Eppendorf	Not applicable	Recruiting	Obesity (BMI > 35), Obesity (BMI > 35) and Diabetes Mellitus, Obesity (BMI > 35) and Dyslipemia, Obesity (BMI > 35) and...	50	Germany	clinicaltrials.gov
October 21, 2026	NCT07884903	Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks	Shanxi Bethune Hospital	Observational	Not yet recruiting	Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)...	25,974	China	clinicaltrials.gov
October 20, 2026	NCT07884058	IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity	University of Yaounde 1	Phase 2	Not yet recruiting	Obesity & Overweight	80		clinicaltrials.gov
October 20, 2026	NCT07883031	Effects of Yerba Mate Supplementation on Metabolic Health, Physical Function, and Cognition in Older Adults With Excess Adiposity	University of North Alabama	Not applicable	Completed	Overweight (BMI > 25), Obesity & Overweight	25	United States	clinicaltrials.gov
October 20, 2026	NCT07882654	A PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN...	EktaH	Phase 2	Not yet recruiting	Obesity / Overweight, Obesity (BMI Equal to or >30)	31	Tunisia	clinicaltrials.gov
October 20, 2026	NCT07881887	A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes	Eli Lilly and Company	Phase 1	Not yet recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	617	Singapore, United States	clinicaltrials.gov
October 19, 2026	NCT07881770	Semaglutide Health Outcomes and Patient Adherence in Australia	Novo Nordisk A/S	Observational	Not yet recruiting	Overweight, Obesity	10,000	Australia	clinicaltrials.gov
October 19, 2026	NCT07881458	A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes	Eli Lilly and Company	Phase 3	Recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	1,000	Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain...	clinicaltrials.gov
October 19, 2026	NCT07881432	A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity	2,115	Argentina, China, Germany, India, Japan, Puerto Rico, South Korea, United...	clinicaltrials.gov
October 19, 2026	NCT07880847	MORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness	Istituti Clinici Scientifici Maugeri SpA	Not applicable	Recruiting	Obesity	34	Italy	clinicaltrials.gov
October 19, 2026	NCT07880717	Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years	Mahidol University	Observational	Recruiting	Diabete Mellitus, Dyslipidaemia, Chronic Kidney Disease, Psychiatric Disorder, Hypertension, Hypothyroidism, Smoking...	93	Thailand	clinicaltrials.gov
October 19, 2026	NCT07880444	Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females	San Diego State University	Not applicable	Not yet recruiting	Poor Sleep Quality	74		clinicaltrials.gov
October 16, 2026	NCT07878299	Comparison of Segmental Body Composition Characteristics in Lipedema and Obesity	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey	Observational	Recruiting	Lipedema, Obesity, Body Mass Index, Bioelectrical Impedance Analysis	200	Turkey (Türkiye)	clinicaltrials.gov
October 16, 2026	NCT07877090	Frontal EEG Dynamics During Anesthesia in Patients With Obesity and Normal Weight	Duzce University	Observational	Recruiting	Obesity (BMI>30), General Anesthesia	60	Turkey (Türkiye)	clinicaltrials.gov
October 15, 2026	NCT07877038	Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Hepatic Impairment and Normal Hepatic Function	Chendu DIAO Pharmaceutical Group CO., LTD.	Phase 1	Not yet recruiting	Obesity, Overweight, T2DM (Type 2 Diabetes Mellitus)	32		clinicaltrials.gov
October 15, 2026	NCT07876531	A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or...	Pfizer	Phase 1	Recruiting	Overweight and/or Obesity, Healthy Participants	144	United States	clinicaltrials.gov
October 15, 2026	NCT07876518	A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity	Pfizer	Phase 1	Not yet recruiting	Overweight and/or Obesity	150		clinicaltrials.gov
October 15, 2026	NCT07875530	VC-AF vs FCV in Obese Patients Undergoing Laparoscopic Surgery	Kocaeli University	Observational	Recruiting	Anesthesia, Mechanical Ventilation, Obesity	78	Turkey (Türkiye)	clinicaltrials.gov
October 15, 2026	NCT07874945	Peripheral Vascular Effects of Insulin in Obesity	University of Missouri-Columbia	Early phase 1	Not yet recruiting	Obesity (BMI>30), Insulin Resistance	64		clinicaltrials.gov
October 15, 2026	NCT07874828	PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A...	M.D. Anderson Cancer Center	Phase 2	Recruiting	Sarcoma,Soft Tissue	30	United States	clinicaltrials.gov
October 15, 2026	NCT07874633	A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or...	Pfizer	Phase 3	Recruiting	Obesity, Overweight	432	China	clinicaltrials.gov
October 14, 2026	NCT07874399	Time-Restricted Eating and Personalized Energy-Restricted Diet in Obese Postmenopausal Women	Gazi University	Not applicable	Not yet recruiting	Obesity (BMI Equal to or >30), Postmenopausal Symptoms, Sleep Quality	40	Turkey (Türkiye)	clinicaltrials.gov
October 14, 2026	NCT07873762	Effects of a 12-Week Individualized Energy-Restricted Diet on Perceived Stress and Serum Cortisol in Adults With Overweight or Obesity	Acibadem University	Not applicable	Completed	Obesity & Overweight	30	Turkey (Türkiye)	clinicaltrials.gov
October 14, 2026	NCT07873645	Study of UBT37034 Injection	The United Bio-Technology (Hengqin) Co., Ltd.	Phase 1	Recruiting	Overweight , Obesity	40	China	clinicaltrials.gov
October 14, 2026	NCT07872904	FutureShape Family	Signe Torekov	Phase 4	Recruiting	Obesity, Overweight	400	Denmark	clinicaltrials.gov
October 13, 2026	NCT07872605	Structured Perioperative Nursing Education and Short-Term Outcomes After Metabolic Bariatric Surgery	General Committee of Teaching Hospitals and Institutes, Egypt	Not applicable	Completed	Obesity, Morbid, Bariatric Surgery Candidate, Obesity	86	Egypt	clinicaltrials.gov
October 13, 2026	NCT07871994	Body Mass Index and Outcomes of Ultrasound-Guided Infraclavicular Brachial Plexus Block	Ankara City Hospital Bilkent	Observational	Not yet recruiting	Obesity (BMI>30)	100		clinicaltrials.gov
October 13, 2026	NCT07871565	Time-Restricted Eating With or Without Energy Restriction in Dyslipidemic Women With Owerweight or Obesity	Acibadem University	Not applicable	Completed	Dyslipidemia, Obesity & Overweight	56	Turkey (Türkiye)	clinicaltrials.gov
October 13, 2026	NCT07871409	Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight	Amgen	Phase 3	Recruiting	Obesity, Overweight	230	Puerto Rico, United States	clinicaltrials.gov
October 13, 2026	NCT07870668	Intermittent Phentermine for Obesity and Body Composition	OSCAR MANUEL TORRES FALCON	Phase 4	Completed	Obesity & Overweight	600	Mexico	clinicaltrials.gov
October 13, 2026	NCT07870538	A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge...	Universitaire Ziekenhuizen KU Leuven	Phase 4	Recruiting	Obesity & Overweight	96	Belgium	clinicaltrials.gov
October 13, 2026	NCT07869758	Gastric On in Obesity Management: Evaluation of the Safety and Efficacy of the 6-Month Gastric Balloon (Prospective)	Rigicon, Inc.	Not applicable	Completed	Obesity & Overweight	42	Turkey (Türkiye)	clinicaltrials.gov
October 9, 2026	NCT07869472	Post-exercise Blood Pressure With Inorganic Nitrate	University of Virginia	Not applicable	Not yet recruiting	Obese Individuals, Central Adiposity	12	United States	clinicaltrials.gov
October 9, 2026	NCT07869355	BRE-13: Mediterranean Diet	University of Illinois Chicago	Not applicable	Not yet recruiting	Dietary Assessment, Dietary and Lifestyle Behaviour Change, Dietary Behavior, Metabolic Health, Obesity, Lifestyle...	30		clinicaltrials.gov
October 9, 2026	NCT07869277	Obesity and Clinical and Cytokine Responses to Periodontal Therapy	Emine Çifcibaşı	Not applicable	Completed	Periodontitis, Obesity (Body Mass Index >30 kg/m2)	80		clinicaltrials.gov
October 9, 2026	NCT07868978	Radial Artery Dimensions and the Effect of Anaesthetic Induction in Morbid Obesity	Hilal Subaşı Artıran	Not applicable	Completed	Obesity, Morbid Catheterization, Peripheral	76	Turkey (Türkiye)	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Novo Nordisk A/S	76	November 5, 2026
Eli Lilly and Company	54	November 4, 2026
Cairo University	28	October 26, 2026
Pfizer	26	November 5, 2026
Amgen	25	November 6, 2026
AstraZeneca	20	November 6, 2026
Shanghai Minwei Biotechnology Co., Ltd	14	September 17, 2026
Hoffmann-La Roche	13	November 5, 2026
Mayo Clinic	11	October 26, 2026
Boehringer Ingelheim	10	October 2, 2026
University of Alabama at Birmingham	10	September 18, 2026
BrightGene Bio-Medical Technology Co., Ltd.	10	February 3, 2026
Kailera	9	November 9, 2026
Pamukkale University	9	November 9, 2026
Assiut University	9	November 6, 2026
Beijing QL Biopharmaceutical Co.,Ltd	9	November 4, 2026
Pennington Biomedical Research Center	9	September 22, 2026
Fujian Shengdi Pharmaceutical Co., Ltd.	9	September 8, 2026
Gan & Lee Pharmaceuticals.	9	August 25, 2026
The United Bio-Technology (Hengqin) Co., Ltd.	8	November 6, 2026

By phase

Phase	New trials	Latest
Not applicable	952	November 9, 2026
Observational	373	November 9, 2026
Phase 1	205	November 9, 2026
Phase 3	144	November 6, 2026
Phase 2	141	November 2, 2026
Phase 4	81	November 6, 2026
Phase 1/2	23	October 27, 2026
Early phase 1	17	October 15, 2026
Phase 2/3	4	October 23, 2026

By country

Country	New trials	Latest
United States	566	November 9, 2026
China	275	November 9, 2026
Turkey (Türkiye)	163	November 9, 2026
Spain	111	November 5, 2026
Canada	100	November 5, 2026
United Kingdom	83	November 5, 2026
Germany	82	November 9, 2026
Italy	78	November 5, 2026
France	68	November 6, 2026
Poland	68	November 5, 2026
Australia	66	November 5, 2026
Denmark	55	November 5, 2026
Egypt	53	October 29, 2026
Mexico	50	October 28, 2026
Brazil	47	November 5, 2026
Japan	47	November 5, 2026
Taiwan	43	October 19, 2026
Argentina	42	November 5, 2026
Greece	39	November 6, 2026
Czechia	38	October 28, 2026
Netherlands	37	November 5, 2026
South Korea	36	November 5, 2026
Puerto Rico	35	November 5, 2026
Belgium	28	November 5, 2026
Sweden	26	September 8, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.